Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Gartner, S. Rovira, I. de Mir, A. Torrent, B. Caurín, G. Sacoto, E. Canino, A. Moreno-Galdó (Barcelona, Spain). Omalizumab for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in children with cystic fibrosis (CF). Eur Respir J 2014; 44: Suppl. 58, 1224

Member's Comments

No comment yet.

Related content which might interest you: Steroid sparing effect of anti-IgE antibody in allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013 The efficacity of omaluzimab in a case series with allergic bronchopulmonary aspergillosis and cystic fibrosis Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment Year: 2015 Vitamin D level in cystic fibrosis patients with allergic bronchopulmonary aspergillosis and aspergillus sensitization Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Changes in total IgE levels predict pulmonary outcome in cystic fibrosis related allergic bronchopulmonary aspergillosis Source: International Congress 2016 – Cystic fibrosis: various aspects Year: 2016 Allergic bronchopulmonary aspergillosis in cystic fibrosis Source: Eur Respir J 2001; 17: 1052-1053 Year: 2001 Allergic bronchopulmonary aspergillosis in cystic fibrosis Source: Eur Respir J 2001; 17: 156 Year: 2001 Allergic bronchopulmonary aspergillosis in cystic fibrosis Source: Annual Congress 2009 - Update on eosinophilic lung diseases Year: 2009 A new risk factor predicts ABPA in patients with cystic fibrosis Source: International Congress 2015 – Cystic fibrosis: assessment and treatment Year: 2015 How useful is the lung ultrasound in cystic fibrosis? Source: International Congress 2016 – Cystic fibrosis: various aspects Year: 2016 LATE-BREAKING ABSTRACT: A relative plasma Elafin deficiency in children with cystic fibrosis (CF) is associated with pulmonary disease Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014 Cystic fibrosis Source: Respipedia Article Year: 2018 Long term follow up of the lung function in cystic fibrosis patients with allergic bronchopulmonary aspergillosis (ABPA) Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009 Lung deposition of inhaled colistimethate sodium in cystic fibrosis patients Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014 Cystic fibrosis fibrosis bronchiectasis Source: Virtual Congress 2020 – Paediatric year in review Year: 2020 Vitamin D serum level and pulmonary exacerbations in children with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013 Bronchodilator responsiveness in children with cystic fibrosis and allergic bronchopulmonary aspergillosis Source: Eur Respir J, 56 (2) 2000175; 10.1183/13993003.00175-2020 Year: 2020 Clinical value of lung clearance index (LCI) among patients with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014 Cystic fibrosis and arthritis in children Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013 Lung MRI findings in children with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014 Diagnosing bronchiectasis and cystic fibrosis Source: International Congress 2018 – ME8 Diagnosing bronchiectasis and cystic fibrosis Year: 2018